Zurueck zur Suche

Reporte zur Charge UT8109KA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
GA 3 FL 2 TX 2 KS 1 IN 1 MO 1

VAERS 2711958

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

moderat
Staat
FL
Alter
29,0
Geschlecht
F
Eingang
09.11.2023
Impfdatum
02.11.2023
Beginn
02.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bronchospasm Dyspnoea

Symptomtext

Couldn't take a full breath for about an hour or two. Went to urgent care where they noted acute bronchospasm, administered Dexamethasone 10mg and Duo nebulizer treatment. Didn't have any other reactions after being discharged but was told to go to the ER if bronchospasm returns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Root canal for abscessed tooth (procedure done the week before, endodontist prescribed Clindamycin)
Vorgeschichte
None
Andere Medikamente
Clindamycin, ib profen, Vitamin D and Zinc
Allergien
None
Vorherige Impfungen
-

VAERS 2720015

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

mild
Staat
FL
Alter
2,0
Geschlecht
F
Eingang
01.12.2023
Impfdatum
30.10.2023
Beginn
31.10.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site cellulitis Injection site erythema Injection site inflammation Injection site pain Injection site swelling

Symptomtext

***Note about Lot number--we believe it was incorrectly documented under the above lot number. We had a changeover in lots from UT8109KA to UT8219KA on that date of service. (I bring this up because we have had subsequently 3 more cases similar to this one involving lot UT8219KA Patient was administered vaccination on 10/30/2023 as a part of her routine, 30 month well visit. The mother called on the following day (10/31/2023) to report that the injection site was red, swollen, and tender. Symptomatic treatment including Benadryl and topical steroids were initiated. On 11/01/2023 the patient was seen in the office for worsening redness, inflammation of the injection site. Acute cellulitis was diagnosed by our physician and the patient was started on topical (mupirocin) and oral (clindamycin) antibiotics. She was seen on the following day (11/02/2023) with evidence of significant improvement after initiation of antibiotic therapy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site cellulitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Recurrent acute otitis media
Andere Medikamente
-
Allergien
Cashew, Pistachio
Vorherige Impfungen
-

VAERS 2715048

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

mild
Staat
KS
Alter
6,0
Geschlecht
M
Eingang
17.11.2023
Impfdatum
16.11.2023
Beginn
17.11.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Significant redness, erythema, warmth at and below injection site, wrapping around arm. Small amount of swelling noted early this morning around 0800, swelling and redness progressed as day went on.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2696473

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge UT8109KA

mild
Staat
TX
Alter
22,0
Geschlecht
F
Eingang
16.10.2023
Impfdatum
04.10.2023
Beginn
04.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache

Symptomtext

Fatigue at the end of the day I received the flu shot and headaches until 10/13/23. Headaches were ongoing in the evenings and I experienced unusual fatigue throughout the day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 2696321

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

mild
Staat
GA
Alter
68,0
Geschlecht
F
Eingang
16.10.2023
Impfdatum
15.09.2023
Beginn
16.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain Pyrexia Rash

Symptomtext

Rash; fever; achey

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none noted
Vorgeschichte
none noted
Andere Medikamente
bp meds
Allergien
none noted
Vorherige Impfungen
flu and covid

VAERS 2684454

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

mild
Staat
GA
Alter
37,0
Geschlecht
F
Eingang
21.09.2023
Impfdatum
15.09.2023
Beginn
16.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site swelling Oedema peripheral

Symptomtext

right arm large amount of swelling around upper arm and at axilla area

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none noted
Vorgeschichte
asthma
Andere Medikamente
none noted
Allergien
none noted
Vorherige Impfungen
-

VAERS 2683594

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

mild
Staat
GA
Alter
35,0
Geschlecht
F
Eingang
19.09.2023
Impfdatum
15.09.2023
Beginn
16.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Injection site oedema Injection site swelling Injection site warmth Oedema peripheral Pain

Symptomtext

Edematous at injection site, warm to touch, large amount of swelling in upper arm and under axilla, pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site oedema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
Asthma
Andere Medikamente
Asthma; hypertension
Allergien
Asthma meds; hypertension meds
Vorherige Impfungen
Patient states she had same reaction after receiving the COVID vaccination

VAERS 2721570

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

gering
Staat
IN
Alter
81,0
Geschlecht
F
Eingang
06.12.2023
Impfdatum
29.11.2023
Beginn
29.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

medical assistant should give FLUZONE HIGH-DOSE QIV and a COVID-19 vaccine. but their MA accidentally ended up giving FLUZONE HIGH-DOSE QIV and FLUZONE QIV NP to the patient with no reported adverse event; medical assistant should give FLUZONE HIGH-DOSE QIV and a COVID-19 vaccine. but their MA accidentally ended up giving FLUZONE HIGH-DOSE QIV and FLUZONE QIV NP to the patient with no reported adverse event; Initial information was received on 29-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 81 years old female patient who experienced medical assistant should give influenza quadrival a-b high dose hv vaccine [Fluzone HIGH-DOSE QUADRIVALENT] and a covid-19 vaccine. but their ma accidentally ended up giving influenza quadrival a-b high dose hv vaccine [Fluzone HIGH-DOSE QUADRIVALENT] and influenza quadrival a-b vaccine [Fluzone QUADRIVALENT] to the patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 20V (CRM197) (Prevnar 20) for Immunisation. On 29-Nov-2023, the patient received a dose of 0.7 ml of suspect influenza quadrival a-b high dose hv vaccine lot UT8131BA, strength, formulation, expiry date was unknown via intramuscular route in the right and left deltoid, received a dose of 0.5 ml of suspect influenza quadrival a-b vaccine Suspension for injection ot UT8109KA, strength, expiry date was unknown via intramuscular route in unknown administration site, received a dose of suspect COVID-19 VACCINE not produced by Sanofi Pasteur lot number not reported via unknown route in unknown administration site for all prophylactic vaccination and medical assistant should give fluzone high-dose qiv and a covid-19 vaccine. but their ma accidentally ended up giving fluzone high-dose qiv and fluzone qiv np to the patient with no reported adverse event (wrong product administered) and (extra dose administered) (latency : same day). Action taken was not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR 20
Allergien
-
Vorherige Impfungen
-

VAERS 2716069

UNKNOWN MANUFACTURER · INFLUENZA (SEASONAL) (NO BRAND NAME) · Charge UT8109KA

gering
Staat
MO
Alter
35,0
Geschlecht
F
Eingang
21.11.2023
Impfdatum
28.10.2023
Beginn
28.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure abnormal Facial paresis Muscular weakness Nervous system disorder

Symptomtext

bilateral and upper extremities weakness, partial facial; bilateral and upper extremities weakness, partial facial; blood pressure issues; presenting neurological issues; Initial information received on 09-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional (nurse). This case involves a 35 years old female patient who experienced bilateral and upper extremities weakness, partial facial, bilateral and upper extremities weakness, partial facial, blood pressure issues and presenting neurological issues after receiving vaccine Influenza Vaccine (Quadrivalent). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Oct-2023, the patient received 0.5 ml dose of suspect Influenza Vaccine (Quadrivalent) produced by unknown manufacturer, formulation: Injection of lot UT8109KA via intramuscular route in the right deltoid for immunization. On 28-Oct-2023, the patient developed bilateral and upper extremities weakness, partial facial (muscular weakness) (facial paresis), blood pressure issues (blood pressure abnormal) and presenting neurological issues (nervous system disorder) (latency: same day) following the administration of Influenza vaccine (Quadrivalent). No lab data was reported. Action taken was not applicable. It was not reported if the patient received a corrective treatment for all events. At time of reporting, the outcome was Not Recovered / Not Resolved for all events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood pressure abnormal
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2699901

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8109KA

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
23.10.2023
Impfdatum
01.10.2023
Beginn
01.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

administering the product in the wrong route with no adverse event; Initial information was received on 13-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and gender patient to whom influenza quadrival A-B vaccine [Fluzone QIV] was administered in the wrong route with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in Oct-2023, the patient received an unknown dose of suspect influenza quadrival A-B vaccine (Suspension for injection) (lot UT8109KA, expiry date: 30-Jun-2024, strength, was unknown) via unknown route in unknown administration site for Influenza(Influenza Immunization) and had administering the product in the wrong route with no adverse event (incorrect route of product administration) (latency: same day). It was reported "Nurse declined to provide any patient information. Only saying it was given a couple of days ago. FLUZONE QUADRIVALENT " Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-